Trajan accelerating adoption and growth of microsampling technologies

Trajan accelerating adoption and growth of microsampling technologies

December 06, 2019

Melbourne, Victoria, Australia – 6 December 2019

Trajan Scientific and Medical (Trajan) announce the appointment of two new roles in their expanding Microsampling business to support global adoption of the portfolio. Led by Dr Anne Collins, the Microsampling business is focused on enabling samples that would not or could not otherwise be taken, to drive information-rich decision making.

The creation of two new roles at Trajan see Dr Florian Lapierre step into the role of Senior Product Specialist, and Pawanbir Singh M.D. as Business Development Manager - Microsampling, UK and Europe. Both roles highlight the evolution of the market and increased demand for patient centric microsampling technologies.

Dr Florian LapierreLocated in Fribourg, Switzerland, Dr Lapierre is responsible for strengthening the connection across functional departments within Trajan by supporting the growing market for microsampling, product knowledge, and assisting with needs for future product development.

Dr Lapierre joined Trajan in 2015 as a Research Scientist within ASTech (ARC Training Centre for Portable Analytical Separation Technologies); during this time he developed the initial hemaPEN® concept, and has been instrumental in the evolution of the technology.

Dr Pawanbir SinghUK-based Dr Singh, is a Medical Doctor who is responsible for developing commercialization blueprints and leading new technology adoption, support growing interest in patient centric sampling technologies.

Dr Singh joined Trajan in 2015 as Market Manager for Health, having previously worked for Leica Biosystems and STEMCELL Technologies.

Dr Collins said, “I’m excited to have Dr Lapierre and Dr Singh strengthen the team in their new roles, and have them focused on leading the technology adoption of Trajan’s portfolio including the hemaPEN technology platform.”

hemaPEN provides a convenient sampling procedure for collection and storage of four dried blood spot (DBS) samples to drive information-rich decision making. Unlike conventional DBS sampling tools, hemaPEN enables collection of an accurate and precise fixed micro-volume, and is designed to maintain sample integrity for quantitative analysis.

Stephen Tomisich, CEO advised that, “The technologies Trajan has developed have real potential to spark changes in approaches to healthcare that will truly deliver upon the Trajan vision - science that benefits people.”

To learn more about Trajan’s microsampling technologies and capabilities visit www.trajanscimed.com/microsampling.

Download
Press release [PDF]

More information
Microsampling
hemaPEN
ASTech

Media contact information
Trajan Scientific and Medical
Tel: +44 (0) 1908 568 844
media@trajanscimed.com

The hemaPEN® is a device supplied for research purposes only. This device is not for therapeutic or diagnostic use.

 




Also in News

Baker Institute research leads to simple tests for heart and diabetes disease
Baker Institute research leads to simple tests for heart and diabetes disease

January 13, 2023

Read More

Trajan Scientific and Medical to license the Baker Institute’s lipidomic analysis methodology and metabolic risk scores algorithms.
Trajan Scientific and Medical to license the Baker Institute’s lipidomic analysis methodology and metabolic risk scores algorithms.

October 10, 2022

Trajan Scientific and Medical, and the Baker Heart and Diabetes Institute, have reached an in-principle understanding for Trajan to license the Baker Institute’s lipidomic analysis methodology and metabolic risk scores algorithms.

Read More

Fully automated MOSH/MOAH workflow with saponification is setting new standards
Fully automated MOSH/MOAH workflow with saponification is setting new standards

September 29, 2022

Since 2010, Axel Semrau, now part of the Trajan family, has enabled the automated determination of MOSH/MOAH in food, feed, beverages, and packaging. By maintaining close contact with users, the CHRONECT Workstation MOSH/MOAH has been continuously enhanced. In this way, a unique system has been created step by step and always at the cutting edge of technology. Our most recent advancement is the automation of the entire sample preparation with saponification and improved epoxidation, which opens up unprecedented possibilities.

Read More